Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 14;16(9):4257-4269.
doi: 10.1039/d5md00179j. Online ahead of print.

Design, synthesis and anti-proliferative activity of 3-aryl-evodiamine derivatives

Affiliations

Design, synthesis and anti-proliferative activity of 3-aryl-evodiamine derivatives

Ming-Li Zhou et al. RSC Med Chem. .

Abstract

Evodiamine and its analogues have received significant attention owing to their antitumor activity. In this work, Pd-catalyzed Suzuki-Miyaura coupling was employed as a key reaction to diversify the natural product evodiamine at the C3 position. A library of new 3-aryl-evodiamine derivatives (6a-6ae) was synthesized. The in vitro antitumor activity of these compounds were evaluated against various cancer cell lines (HCT116, 4T1, and HepG2). Most of them showed better cytotoxicity than evodiamine. Herein, the primary structure-activity relationship of 3-aryl-evodiamine derivatives was briefly discussed. In particular, the methylsulfonylbenzene derivative 6y exhibited excellent anti-proliferative activity against HCT116 (IC50 = 0.58 ± 0.04 μM) and 4T1 cells (IC50 = 0.99 ± 0.07 μM), providing a promising evodiamine analogue for antitumor drug development. This work would offer new insights for the development of evodiamine-based compounds.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

References

    1. Gavaraskar K. Dhulap S. Hirwani R. R. Fitoterapia. 2015;106:22–35. doi: 10.1016/j.fitote.2015.07.019. - DOI - PubMed
    1. Tan Q. Y. Zhang J. Q. Adv. Exp. Med. Biol. 2016;929:315–328. doi: 10.1007/978-3-319-41342-6_14. - DOI - PubMed
    1. Fang Z. L. Tang Y. Q. Ying J. M. Tang C. L. Wang Q. W. Chin. Med. 2020;15:82. - PMC - PubMed
    1. Panda M. Tripathi S. K. Zengin G. Biswal B. K. Cell Biol. Toxicol. 2023;39:1–31. - PubMed
    1. Dong G. Q. Wang S. Z. Miao Z. Y. Yao J. Z. Zhang Y. Q. Guo Z. Z. Zhang W. N. Sheng C. Q. J. Med. Chem. 2012;55:7593–7613. doi: 10.1021/jm300605m. - DOI - PubMed

LinkOut - more resources